Hydration Pharmaceuticals Co. Ltd. (AU:HPC) has released an update.
Hydration Pharmaceuticals Co. Ltd. reported a significant 43% reduction in net operating cash use compared to last year, achieving a record low and marking its seventh consecutive quarter of reductions. Despite inventory issues leading to unshipped orders, the company saw a net sales increase of 2% over the previous quarter, with adjusted sales reflecting a 23% growth when accounting for these unshipped orders. The company also signed an amended funding agreement with Pure Asset Management to seek the sale of the company for stakeholders’ benefit.
For further insights into AU:HPC stock, check out TipRanks’ Stock Analysis page.
